About Us

Advisory Boards

Scientific Advisory Board

We are supported by a world-class scientific advisory board that comprises highly acclaimed scientific leaders across immunology and oncology fields and we’re guided by the expertise of world-renowned cell therapy experts.

A2 Bio Science Advisory Board Mark Davis

Mark Davis, Ph.D.

Stanford, Human Immunology & TCRs

A2 Bio Science Advisory Board David Maloney

David Maloney, M.D., Ph.D.

Fred Hutchinson Cancer Center, Cancer Cell Therapy

A2 Bio Science Advisory Board Marcela Maus

Marcela Maus, M.D., Ph.D.

Harvard University, Translational Cell Therapy

A2 Bio Science Advisory Board Robert Schreiber

Robert Schreiber, Ph.D.

Washington University, Immunology & Neo-antigens

A2 Bio Science Advisory Board George Tsokos

George C. Tsokos, M.D.

Harvard University, T cell Biology

Clinical Advisory Board

Marco Davila, M.D., Ph.D.

Roswell Park Comprehensive Cancer Center, Medical Oncology

William Go, M.D., Ph.D.

Chief Development Officer of BioMarin

Frederick Locke, MD

Moffitt Cancer Center, Blood and Marrow Transplant and Cellular Immunotherapy

David Maloney, M.D., Ph.D.

Fred Hutchinson Cancer Center, Cancer Cell Therapy

Marcela Maus, M.D., Ph.D.

Harvard University, Translational Cell Therapy

Learn About Our Investors